KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Notes Payables (2016 - 2024)

Emergent BioSolutions has reported Notes Payables over the past 8 years, most recently at $800000.0 for Q3 2024.

  • For Q3 2024, Notes Payables fell 99.81% year-over-year to $800000.0; the TTM value through Sep 2024 reached $800000.0, down 99.81%, while the annual FY2023 figure was $413.7 million, 56.78% down from the prior year.
  • Notes Payables for Q3 2024 was $800000.0 at Emergent BioSolutions, down from $415.2 million in the prior quarter.
  • Over five years, Notes Payables peaked at $957.3 million in Q4 2022 and troughed at $800000.0 in Q3 2024.
  • A 5-year average of $231.0 million and a median of $31.6 million in 2021 define the central range for Notes Payables.
  • Biggest five-year swings in Notes Payables: soared 2929.43% in 2022 and later crashed 99.81% in 2024.
  • Year by year, Notes Payables stood at $33.8 million in 2020, then fell by 6.51% to $31.6 million in 2021, then soared by 2929.43% to $957.3 million in 2022, then crashed by 56.78% to $413.7 million in 2023, then crashed by 99.81% to $800000.0 in 2024.
  • Business Quant data shows Notes Payables for EBS at $800000.0 in Q3 2024, $415.2 million in Q2 2024, and $459.2 million in Q1 2024.